Ameriprise Financial Inc Marker Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.68 - $4.85 $28,558 - $51,681	-10,656 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.1 - $9.0 $43,689 - $95,904	10,656 New	10,656 $54,000
Q1 2019 May 15, 2019	SELL	$5.1 - $6.71 $12,750 - $16,775	-2,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.2 - $9.74 $10,500 - $24,350	2,500 New	2,500 $14,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $278M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.